BNED vs TSLA

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no Altman Z-Score available, leaving bankruptcy risk unconfirmed but concerning given high leverage. Despite a low current P/E of 12.89 compared to sector average of 53.76, the negative forward P/E (-0.25) and collapsing earnings growth (-62% YoY) signal deteriorating profitability. The stock trades above the Graham Number of $11.53 but well above the intrinsic value of $4.97, suggesting overvaluation on a conservative basis. Persistent negative earnings surprises, declining ROE, and weak insider sentiment (40/100) further undermine confidence in a near-term turnaround.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.